Search

Robert M Fesinmeyer

from Thousand Oaks, CA
Age ~49
Get Report
Also known as:
Robert Matthew Fesinmeyer
Related to:
Jennifer PrayRyan J Dann, 43Jennifer B Fesinmeyer, 46Erin E Dann, 45Charles A Dann, 72Phala J Dann, 80Wallace J FesinmeyerWallace FesinmeyerMegan D Fesinmeyer, 49
Connected to:
Nicole M Feskanich, 44Rachel A Feskanich, 43Elbert F Feske, 48Melissa J Fesko, 36Cynthia A Fesler, 68Michele M Fesler, 47Erin E Fesnak, 43Laverne G Fesperman, 71Paul Fessak, 66Senait S Fessehai, 32

Robert Fesinmeyer Phones & Addresses

  • Thousand Oaks, CA
  • 19230 Forest Park Dr, Lake Forest Park, WA 98155 (206) 417-8017
  • 19230 Forest Park Dr NE #310, Seattle, WA 98155 (206) 417-8017
  • 2135 122Nd St, Seattle, WA 98101 (206) 417-8017
  • Encinitas, CA

Publications

Us Patents

Vegfr-Fc Fusion Protein Formulations

View page
US Patent:
20230025418, Jan 26, 2023
Filed:
Sep 14, 2022
Appl. No.:
17/932255
Inventors:
- Thousand Oaks CA, US
Robert Matthew FESINMEYER - Newbury Park CA, US
Monica Michelle GOSS - Newbury Park CA, US
Sekhar KANAPURAM - Thousand Oaks CA, US
Rahul Rajan KAUSHIK - Newbury Park CA, US
Sai Chakradhar PADALA - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07K 14/71
A61K 9/00
Abstract:
VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEGFR-Fc fusion protein is aflibercept.

Formulations Comprising A Tris Buffer And A Protein

View page
US Patent:
20210353713, Nov 18, 2021
Filed:
Oct 25, 2019
Appl. No.:
17/288139
Inventors:
- Thousand Oaks CA, US
Robert Matthew FESINMEYER - Newbury Park CA, US
Rahul Rajan KAUSHIK - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 38/17
A61K 9/00
A61K 47/40
A61K 47/18
A61K 47/26
Abstract:
Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept. In some embodiments, the formulation comprises a Tris buffer.

Excipients To Reduce The Viscosity Of Antibody Formulations And Formulation Compositions

View page
US Patent:
20200352857, Nov 12, 2020
Filed:
Apr 24, 2018
Appl. No.:
16/609448
Inventors:
- THOUSAND OAKS CA, US
Robert Matthew FESINMEYER - Newbury Park CA, US
Rulin QIAN - Newbury Park CA, US
Assignee:
AMGEN INC. - THOUSAND OAKS CA
International Classification:
A61K 9/08
C07K 16/24
C07K 16/40
A61K 9/19
A61K 47/18
Abstract:
This invention concerns a series of excipients capable of effectively reducing the viscosity of protein formulations. The viscosity reducing excipients are oligopeptides (e.g., dipeptides, tripeptides) comprising at least one arginine. The peptides may also include basic or acidic or hydrophilic or hydrophobic/aromatic amino acids. An arginine residue may be either at the amino or the carboxyl end of the oligopeptide.

Vegfr-Fc Fusion Protein Formulations

View page
US Patent:
20200338164, Oct 29, 2020
Filed:
Nov 16, 2018
Appl. No.:
16/764463
Inventors:
- Thousand Oaks CA, US
William J. CALLAHAN - Thousand Oaks CA, US
Robert Matthew FESINMEYER - Newbury Park CA, US
Rahul Rajan KAUSHIK - Newbury Park CA, US
Sai Chakradhar PADALA - Thousand Oaks CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 38/18
A61K 9/00
A61K 47/14
A61K 47/18
A61K 47/26
A61K 47/34
A61K 47/02
Abstract:
Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept.

Vegfr-Fc Fusion Protein Formulations

View page
US Patent:
20200255496, Aug 13, 2020
Filed:
Sep 17, 2018
Appl. No.:
16/647902
Inventors:
- Thousand Oaks CA, US
Robert Matthew FESINMEYER - Newbury Park CA, US
Monica Michelle GOSS - Newbury Park CA, US
Sekhar KANAPURAM - Thousand Oaks CA, US
Rahul Rajan KAUSHIK - Newbury Park CA, US
Sai Chakradhar PADALA - Thousand Oaks CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 14/71
A61K 9/00
Abstract:
VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEG-FR-Fc fusion protein is aflibercept.
Control profile
Robert M Fesinmeyer from Thousand Oaks, CA, age ~49 Get Report